Novel Coronavirus (COVID-19) Resources and Special Communications

Below are links to AHA resources developed in response to novel coronavirus (COVID-19). For all coronavirus resources and news updates, visit our COVID-19 page.

Latest

COVID-19 continues to dramatically impact the short- and long-term strategies of hospitals and health systems.
This document requests action to spur Congress to fully reinstate June reporting requirements for the COVID-19 Provider Relief Fund during its ‘lame-duck session.’
This document requests action to spur Congress to fully reinstate June reporting requirements for the COVID-19 Provider Relief Fund during its ‘lame-duck session.’
The spread of COVID-19 revealed systemic cracks in the social needs and public health infrastructure of communities — inequities that have existed for decades. A Kaiser Permanente survey of 2,900 of its members earlier this year illustrates the disproportionate impact the pandemic is having on the poor and people of color.
An AHA Member Call on Allocation and Distribution of Operation Warp Speed (OWS) Therapeutics with Nancy Foster and John Redd, MD, CMO, ASPR, including remdesivir and monoclonal antibody (MAB) therapeutics like bamlanivimab through the Emergency Use Authorization (EUA).
Confronting the challenges of the pandemic is imperative to saving American lives. Real-time data and information on the supply of therapeutics, testing supplies, personal protective equipment, ventilators, hospital bed capacity and workforce availability to plan for further deployment of the nation’s assets needs to be shared to save countless lives.
The recently launched AHA Living Learning Network (LLN) provides essential resources through a peer-to-peer community of health care professionals dedicated to helping hospitals and health systems recover, rebuild and reimagine health care while responding to the pandemic.
The AHA will host a call on Monday, Nov. 16, from 4-5 p.m. ET with leaders from the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and other federal agencies to discuss the delivery and administration of monoclonal antibody therapies.
With the COVID-19 pandemic reaching the point in which vaccines against the coronavirus may soon be publicly available, the AHA is helping hospitals and health systems prepare for their arrival, while promoting public confidence in Food and Drug Administration-approved SARS-CoV-2 vaccines.
In a study of 106,543 patients hospitalized for COVID-19 between March and July, 9% were readmitted to the same hospital
The America Hospital Association (AHA) will host a webinar Nov. 19 at 1 p.m. ET with senior health care leaders
The Veterans Health Administration (VHA) recently released a report detailing the organization’s efforts to respond to the COVID-19 pandemic
Eligible family members of front-line health care workers and volunteers who lose their lives to COVID-19 can apply to the Brave of Heart Fund
Strategies and tools to address burnout as health care professionals continue to care for COVID-19 patients
This week, the National Academies of Sciences, Engineering, and Medicine (NASEM) released a report examining the advantages
Last week, the Food and Drug Administration (FDA) issued an emergency use authorization (EAU) for the first serology test